[MK TEST DO NOT TOUCH] Trimetazidine new formulation redefining angina control in daily practice
12 Mar 2021
byLaura Dobberstein; Pandelis K Athanasias, MBBS, MRCOG; Karolina Afors, MBBS; Samina M Dornan, MD, MRCOG; Gabriel Angelo Serrano; Jackey Suen; Naomi Adam, MSc (Med), Category 1 Accredited Education Provider, Royal Australian College of General Practitioners; Dr. Patricia Poon, Specialist in Clinical Oncology, Hong Kong
Chronic coronary syndrome (CCS) remains a leading cause of death and disability worldwide. The dual goals of CCS management is to prevent future cardiac events, such as myocardial infarction and death, and to reduce ischaemia and relieve angina symptoms, says Prof Peter Yan, consultant cardiologist and medical director, Peter Yan Cardiology Clinic, Gleneagles Medical Centre, Singapore, during a Servier-sponsored virtual symposium.